1. Peter MacCallum Cancer Centre, Melbourne, VIC, Australia;
2. St Vincent’s Hospital, Fitzroy, VIC, Australia;
3. Department of Medicine, University of Melbourne, Parkville, VIC, Australia;
4. Royal Melbourne Hospital, Parkville, VIC, Australia;
5. Monash Health, Clayton, VIC, Australia;
6. Clinical Haematology Unit, Monash University, Clayton, VIC, Australia;
7. University College London Hospital Foundation Trust, London, United Kingdom;
8. Maria Sklodowska-Curie National Institute of Oncology, Krakow, Poland;
9. Flinders Medical Centre, Adelaide, SA, Australia;
10. Sir Charles Gairdner Hospital, Perth, WA, Australia;
11. Department of Lymphoma/Myeloma, University of Western Australia, Perth, WA, Australia;
12. St James’s University Hospital, Leeds, United Kingdom;
13. Department of Haematology, Princess Alexandra Hospital, Brisbane, QLD, Australia;
14. School of Medicine, University of Queensland, Brisbane, QLD, Australia;
15. Unit of Hematology, Department of Medicine, Karolinska Universitetssjukhuset–Karolinska Institutet, Stockholm, Sweden;
16. Hospital Universitario de Salamanca, Salamanca, Spain;
17. Royal Bournemouth and Christchurch Hospital, Bournemouth, United Kingdom;
18. Royal North Shore Hospital, Sydney, NSW, Australia;
19. ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy;
20. Bing Center for Waldenstrom Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA;
21. Department of Medicine, Harvard Medical School, Boston, MA;
22. Szpital Uniwersytecki No 2 im Dr Jana Biziela, Bydgoszcz, Poland;
23. Department of Hematology, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, Bydgoszcz, Poland;
24. Amyloidosis and Myeloma Unit, Department of Hematology, Hospital Clinic of Barcelona, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain;
25. Fourth Department of Internal Medicine - Haematology, Charles University Hospital and Faculty of Medicine, Hradec Králové, Czech Republic;
26. Department of Medicine, University of Washington and the Seattle Cancer Care Alliance, Seattle, WA;
27. Colorado Blood Cancer Institute, Denver, CO;
28. ASST Spedali Civili di Brescia, Lombardia, Italy;
29. City of Hope National Medical Center, Duarte, CA;
30. Ospedale Civile S Maria delle Croci, Azienda Unità Sanitaria Locale (AUSL), Ravenna, Italy;
31. First Department of Medicine, First Faculty of Medicine, Charles University, General Hospital, Prague, Czech Republic;
32. University Medical Center Utrecht, Utrecht, The Netherlands;
33. Comprehensive Cancer Center Ulm–Universitätsklinikum Ulm, Ulm, Germany;
34. Service d'Hématologie Clinique, Sorbonne University, Pitié Salpêtrière Hospital, Paris, France;
35. Haematology Department, University of Sydney, Concord, NSW, Australia;
36. Department of Haematology, Concord Repatriation General Hospital, Sydney, Concord, NSW, Australia;
37. BeiGene USA, Inc, San Mateo, CA; and
38. Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece